Italian car parts manufacturer CLN-Coils Lamiere Nastri SpA is in talks to sell assets to Stellantis NV, its main customer, amid discussions with lenders to cut its debt.

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global ...

Italian car-parts manufacturer CLN-Coils Lamiere Nastri SpA asked bank creditors to write down about 90% of their unsecured loans as it seeks to drastically reduce its debt amid the crisis in the ...

CLN-978 is an advanced, highly potent CD19 x CD3 bispecific T-cell engager designed to target and destroy harmful cells by binding to CD19 on B cells and CD3 on T cells. It is engineered to have a ...